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Dialysis neutropenia: The role of the cytoskeleton. Dialysis neutropenia
is the result of pulmonary sequestration of neutrophils after complement
activation by the dialyzer membrane. Increased expression of neutrophil
adhesion receptors, such as CD11b/CD18, suggests that neutrophil adhe-
sion to the capillary endothelium is a possible mechanism. An alternative
hypothesis is that the complement fragment C5a modulates neutrophil
mechanical properties via the cytoskeleton–largely filamentous actin
(F-actin)–stiffening them and thereby slowing their passage through the
pulmonary capillaries. To investigate this hypothesis, we developed an
assay to measure the F-actin content of neutrophils in whole blood using
flow cytometry and the stain NBD-phallacidin. We measured neutrophil
F-actin content during hemodialysis of patients with polysulfone (N 5 6),
Hemophan (N 5 6), and Cuprophan membranes sterilized with either
ethylene oxide (N 5 5) or steam (N 5 6). Cell counts, neutrophil and
monocyte CD11b expression and plasma C5a concentratio ns were also
measured. The results confirm the strong relationship between the degree
of neutropenia, increases in CD11b expression and plasma C5a levels
reported by previous researchers. Modulation of the F-actin content of
neutrophils was also strongly related to C5a levels, indicating that the
neutrophil cytoskeleton is active during dialysis. Modeling of cell counts
suggests that with Cuprophan a substantial fraction of neutrophils and
monocytes are sequestered before they even pass through the dialyzer,
suggesting some form of systemic activation of these cells. Evidence for
systemic activation was also seen in measurements of F-actin content, but
not CD11b expression, a finding that strengthens the case for the
involvement of the cytoskeleton in dialysis neutropenia.
Hemodialysis is accompanied by activation of the complement
cascade leading to production of C5a, a powerful chemoattractant
[1]. This is associated with a transient leukopenia, as the number
of neutrophils and monocytes in circulation declines in the first 15
minutes of dialysis and subsequently rebounds [2]. The magnitude
of the C5a production and the attendant neutropenia are both
strongly dependent on the type of dialyzer [3] or dialyzer reuse [4],
suggesting a causal link. Further evidence that C5a is the cause of
dialysis neutropenia is found from animal models, where C5a
infusion also causes a transient neutropenia [5], and depletion of
the complement system by cobra venom factor substantially
abrogates the neutropenia associated with sham dialysis in pigs
[6].
The neutrophils that disappear from circulation during dialysis
neutropenia are sequestered in the pulmonary capillaries [7], but
the mechanism of sequestration remains a matter of debate. The
most widely held theory is that activated neutrophils adhere to the
endothelial walls of the pulmonary capillaries, the first vascular
surface they come in contact with after leaving the dialyzer [8].
This adherence is thought to be mediated by the adhesion
receptor CD11b/CD18 (Mac-1, CR3), which is up-regulated on
the surface of circulating neutrophils early in dialysis [9]. As with
the depth of neutropenia, the magnitude of CD11b up-regulation
is a function of the type of dialyzer [10] or dialyzer reuse [9],
suggesting a direct relationship with the amount of C5a produc-
tion during blood-membrane contact with the dialyzer. In vitro
stimulation of neutrophils by C5a also up-regulates CD11b/CD18
[9], and increases CD11b/CD18 dependent adhesion of neutro-
phils to endothelial cells [11, 12].
However, significant evidence against a role for CD11b/CD18
dependent adhesion in chemoattractant-induced neutropenia in
animals is revealed by the use of the antibody IB4 directed against
CD18. Antibody IB4 blocks the adhesion to umbilical vein
endothelial cells of neutrophils stimulated with phorbol dibuytrate
in vitro [13]. On intravenous injection, IB4 blocked accumulation
of neutrophils in rabbit skin following local (intradermal) injec-
tion of the chemoattractant zymosan activated serum, confirming
a significant role for the CD11/CD18 family of adhesion receptors
in the extravasation of neutrophils. Yet the same intravenous
dosing regimen of IB4 did not block the neutropenia induced in
rabbits by systemic (intravenous) injection of another chemoat-
tractant, N-formyl-methionyl-leucyl-phenylalanine (fMLP). This
evidence suggests that mechanisms other than CD11b/CD18-
dependent adhesion may be responsible for chemoattractant
induced accumulation of neutrophils in the lungs [14].
We suggest here an alternative mechanism for dialysis neutro-
penia. Stimulation of neutrophils with C5a (as with fMLP) causes
rapid polymerization of monomeric globular actin (G-actin) to
filamentous actin (F-actin), a major cytoskeletal component [15,
16]. This process is accompanied by a rapid increase in stiffness of
the cells. Neutrophils (mean diameter 8 mm) are typically larger
than pulmonary capillaries (mean diameter 5.5 mm), and hence
must deform to enter them [17]. It has been estimated that a
typical neutrophil must negotiate approximately 60 capillary seg-
ments in its passage through the lungs. If activated neutrophils are
stiffer, their passage is likely to be slower; hence, their numbers
will increase in the lungs and decline in the circulation [18].
F-actin polymerization has been measured in isolated neutro-
phils [15, 19], and increases in stiffness have been implicated as
the mechanism of neutropenia in animal models [20] and for the
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retention of neutrophils in artificial pores [17, 21]. However, in
order to investigate if F-actin polymerization is a possible factor in
dialysis neutropenia, an assay for the measurement of neutrophil
F-actin content in whole blood samples is required.
Therefore, we developed an assay for measuring the F-actin
content of neutrophils in whole blood. The assay was used to
determine if F-actin polymerization occurs during dialysis and if
this is a plausible mechanism of dialysis neutropenia. CD11b
expression was also measured to determine if there is any
evidence that favors the F-actin mechanism over the postulated
CD11b-dependent mechanism.
METHODS
Patients and membranes
Twenty-four patients (7 female and 17 male) on chronic
hemodialysis agreed to participate in the study. The patients had
been undergoing stable treatment for at least the previous three
months on one of four dialyzers listed in Table 1. Six patients
treated with each membrane type were chosen. Patients were
paired so that each of the six possible membrane combinations
was represented twice. They were then studied in pairs during
their normal dialysis sessions. All patients received heparin as an
anticoagulant. Ultimately one patient (CP-E) was excluded from
the analysis as a result of an eventful and interrupted dialysis due
to poor vascular access.
Antibodies and other reagents
Fluorescein isothiocyanate (FITC) conjugated monoclonal an-
tibodies against CD11b and an IgG1a isotype control were
purchased from Immunotech. A phycoerythrin (PE) conjugated
anti-CD14 antibody was from Becton Dickinson. Nitrobenzox-
adiazolyl (NBD) phallacidin was from Molecular Probes.
Blood samples
Blood samples (2 ml) were obtained pre-dialysis from the
arterial cannula and from the arterial (afferent) and venous
(efferent) lines of the dialyzer after 5, 10, 15, 30, 60 and 180
minutes of dialysis. Cell counts, plasma C5a concentrations,
neutrophil F-actin content and neutrophil and monocyte CD11b
expression were measured as described below. Additional arterial
blood samples (1 ml) were taken at 2, 20 and 40 minutes for cell
counts alone.
Neutrophil F-actin measurements
Two drops (approximately 100 ml) of blood was placed into 2 ml
of Becton Dickinson FACSlyse (about 1.5% formaldehyde, 5%
diethylene glycol) solution 30 seconds after sampling. (The F-
actin assay was insensitive to the actual volume of blood over a
range from 20 to 200 ml; however, the timing is important for
obtaining reproducible results.) The mixture was immediately
vortexed and allowed to stand for 10 minutes at room tempera-
ture. It was subsequently washed twice with cold PBS, the pellet
was resuspended in 350 ml PBS, and the samples were stored on
ice. Subsequently, 300 ml of this cell suspension was stained with
3.15 3 1027 M NBD-phallacidin and incubated for one hour at
room temperature. Ten thousand events were acquired on a flow
cytometer (Becton Dickinson FACScan) and the neutrophils were
gated on light scatter properties. Monocytes were difficult to
resolve from other cell types during neutropenia, and hence it was
not possible to determine the kinetics of monocyte F-actin
content. The median channel number (MdCN) in the green
fluorescence detector was recorded (using log amplification and
256 channels per decade) and converted to a linear value using the
following formula:
Fluorescent Intensity 5 FI 5 10
MdCN
256 (Eq. 1)
Separate experiments demonstrated that NBD-phallacidin bind-
ing to neutrophils using this assay was saturable, and virtually
abolished when the neutrophils were pre-incubated with 6.6 3
1025 M unlabeled phalloidin, confirming that the assay is specific
to filamentous actin [22].
Antigen measurements
The remainder of blood was immediately placed in cold EDTA
(final concentration 0.01 M), mixed and kept on ice to prevent
further complement activation and receptor mobilization. Subse-
quently, 900 ml of blood was removed for C5a determination and
the balance used for antigen determination. Tubes were prepared
with FITC-anti-CD11b (20 ml of 0.2 mg/ml) or FITC-IgG1a (20 ml
of 0.2 mg/ml). Each also contained PE-anti-CD14 (5 ml of 0.1
mg/ml) as a monocyte marker and was made up to 50 ml with
sterile PBS. The tubes were placed on ice and 50 ml of blood from
each sample was added to each. The tubes were incubated for four
hours on ice, before the blood was lysed and fixed in a single step
with 2 ml of FACSlyse. The cells were washed twice and resus-
pended with 250 ml of PBS, before 10000 events were acquired on
the flow cytometer. Monocytes and neutrophils were separately
gated based on side scatter, and CD14 expression and the median
channel number from the green fluorescence detector for each
cell type was recorded. Median channel numbers were converted
to a linear fluorescence intensity scale using the formula above.
Net (NFI) binding of the antibodies to CD11b was calculated by
subtracting the fluorescence intensity of the isotype control
(IgG1a).
NFI 5 FI 2 FIcontrol (Eq. 2)
Cell counts
Total white blood cell counts were determined using a Coulter
Counter. Differential counts for monocytes and neutrophils were
determined from the proportion of these cells measured by the
flow cytometer. For the 2, 20 and 40 minutes samples, blood
Table 1. Details of the dialyzers used in the study
Brand Model Membrane Form Area m2 Sterilization Abbreviation
Gambro N5 Cuprophan Plate 1.4 Ethylene oxide CP-E
Fresenius E4S Cuprophan Fiber 1.6 Autoclave CP-S
Salvia Ma12H Hemophan Fiber 1.2 Autoclave HP
Fresenius F60 Polysulfone Fiber 1.25 Ethylene oxide PS
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samples were also stained with PE-anti-CD14 to enable differen-
tial counts.
C5a determination
C5a concentrations in plasma were determined by ELISA
(Behring). In order to ensure that the C5a concentrations were
within the measurement limit of 10 ng/ml, venous samples from
Cuprophan and Hemophan dialyzers were diluted tenfold and
twofold, respectively. Other samples were not diluted.
Statistical analysis
Statistical analysis was performed on predialysis and peak (or
nadir) cell counts, complement levels, neutrophil F-actin content,
and antigen expression on neutrophils and monocytes [23]. Dif-
ferences between membranes were assessed using one-way anal-
ysis of variance with Duncan’s multiple range test and a signifi-
cance level of 0.05 or 0.01. Predialysis levels were analyzed
without transformation as were minimum cell counts. In order to
stabilize the variances, peak complement levels were analyzed as
the logarithm of concentration whereas maximum F-actin content
and maximum antigen expression were analyzed as the logarithm
of the ratio to the predialysis level. The error bars on all graphs
represent one SEM.
RESULTS
Prior to dialysis (Table 2) there were no significant differences
between membranes for cell counts, F-actin content of neutro-
phils, CD11b expression on neutrophils or monocytes, or C5a
concentrations (P . 0.05).
Neutrophil and monocyte counts (Fig. 1 A, B) fell rapidly after
the start of dialysis before rebounding, consistent with many
previous reports [2, 1]. The decline was greatest with the two
Cuprophan membranes, intermediate with Hemophan and small-
est for polysulfone. Plasma C5a concentrations also displayed a
familiar pattern (Fig. 1 C, D), that is, the venous and arterial C5a
levels were highest with the Cuprophan membranes, intermediate
with Hemophan and lowest with polysulfone. Arterial C5a rose
and fell in parallel with venous C5a, with only a short delay. The
particularly strong association between leukopenia and comple-
ment activation is illustrated in Figure 4.
The pattern of CD11b expression on neutrophils was also
consistent with previous reports (Fig. 2 A, B) [9, 10]. In venous
blood the expression of CD11b rose sharply at the start of dialysis,
peaked at 30 minutes (Cuprophan) or earlier, then declined
slowly. Maximum levels were three to four times resting levels.
Levels in arterial blood increased slowly over the entire three
hours with Cuprophan and Hemophan. The increase in antigen
expression on monocytes was less, as a ratio to resting levels, than
on neutrophils but the pattern was similar (Fig. 2 C, D). With
arterial monocytes there was a pronounced delay in the appear-
ance of increased expression of CD11b.
The F-actin content in venous neutrophils rose sharply at the
start of dialysis (Fig. 3A). With Hemophan and Cuprophan,
F-actin content reached a maximum of about 2.5 times the
pre-dialysis level and remained at this level, which may represent
a maximal level of stimulation, until the end of dialysis. Venous
neutrophil F-actin content for polysulfone peaked at 1.8 times the
pre-dialysis level only five minutes into dialysis (at the same time
as peak venous C5a) and then declined steadily.
In contrast to the venous results, arterial neutrophil F-actin
content was clearly less affected by dialysis with Hemophan
compared with the two Cuprophan membranes (Fig. 3B). Again,
polysulfone produced the smallest increase in F-actin content.
The timing of the initial peak in arterial F-actin content corre-
sponded approximately to the nadir of neutropenia: 30 minutes
for Cuprophan, 15 minutes for Hemophan, and 5 to 10 minutes
for polysulfone. However, with Cuprophan, the F-actin content
did not decline appreciably as neutrophils returned to circulation.
DISCUSSION
In interpreting leukocyte kinetics during dialysis it helps to
compare the observed kinetics with a hypothetical model. If all
cells that traverse the dialyzer, and only those cells, sequester in
the lungs or elsewhere and do not return to the circulation, then
cell counts can be modeled as a single compartment with first-
order removal. Under these assumptions cell counts would fall
Table 2. Patient details and pre-dialysis data
Cuprophan
CP-E
Cuprophan
CP-S
Hemophan
HP
Polysulfone
PS
Patients
Number 5 6 6 6
Male:Female 4:1 5:1 3:3 4:2
Age 60 (52–67) 49 (32–69) 67 (36–78) 53 (31–75)
Weight kg 74.4 (19.3) 72.2 (10.0) 63.2 (6.0) 69.4 (14.8)
Blood flow rate ml/min 212 (27) 223 (26) 223 (26) 218 (22)
Hemoglobin g/dl 10.4 (1.1) 10.8 (1.3) 9.8 (1.3) 9.7 (1.2)
Cells
Total white blood cells 103/ml 7.6 (2.3) 8.6 (3.0) 6.5 (1.8) 6.6 (1.6)
Neutrophils 103/ml 4.9 (1.7) 5.3 (2.5) 4.2 (1.4) 4.3 (1.1)
Monocytes 103/ml 0.61 (0.33) 0.77 (0.29) 0.58 (0.19) 0.41 (0.16)
Complement
C5a ng/ml 0.53 (0.13) 0.61 (0.29) 0.82 (0.50) 0.50 (0.17)
Neutrophil
F-actin FI 339 (37) 361 (32) 355 (52) 344 (76)
CD11b NFI 154 (33) 143 (46) 164 (57) 130 (41)
Monocyte
CD11b NFI 76.4 (7.3) 88.2 (12.9) 91.4 (14.4) 82.0 (11.8)
Results are given as the mean (range) or as mean (SD).
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exponentially according to Equation 3, where N(t) is the cell count
at time t, Qb is the (dialyzer) blood flow rate and Vb is the blood
volume.
Relative cell count 5
N~t!
N~0!
5 2
Qb
At
Vb
(Eq. 3)
The dashed lines in Figure 1 A and B represent this model with
Qb 5 225 ml/min, and Vb 5 4500 ml. A blood flow of 225 ml/min
is close to the mean blood flow rates for each of the four
membrane groups, which are estimated to range from 212 to 223
ml/min (Table 2). A blood volume of 4500 ml is also a reasonable
mean for such a group of patients. Hence, this line represents the
approximate maximum rate of neutrophil removal if passage
through the dialyzer is a prerequisite for sequestration.
The neutrophil counts for all membranes follow this line
initially. Neutrophils appear to be leaving the circulation at the
same rate at which they are passing through the dialyzer. It seems
reasonable to conclude that these are the same neutrophils; after
leaving the blood circuit they lodge in the lungs for at least a short
time regardless of membrane type. The bulk of the neutrophils, on
the other hand, appear to be unaffected and to traverse the
capillary beds of the body unscathed. Otherwise the cell count
would fall faster. Then at about ten minutes, the neutrophil counts
with Cuprophan start to fall more rapidly, indicating that systemic
neutrophils must also be leaving the circulation. In contrast,
neutrophil counts for polysulfone and then Hemophan depart
above the predicted curve, possibly because the neutrophils
sequestered earliest are beginning to return to circulation. The
results for monocytes were similar except that the cell counts with
Hemophan also deviated below the first-order model. This kinetic
analysis is consistent with an original observation by Kaplow and
Gofinet [2], that cells were leaving the circulation faster than they
were entering the dialyzer.
The sequestration of neutrophils that have not passed through
the dialyzer suggests either that these systemic neutrophils are
becoming activated or that they are aggregating with neutrophils
that were activated by passage through the dialyzer. A third
possibility, that the sequestered neutrophils block the passage of
non-activated neutrophils, can be ruled out on geometric and
rheological grounds [24, 25].
Aggregation of neutrophils induced by activation of the alter-
native pathway of the complement cascade is a mechanism of
neutropenia that has previously received experimental support
[26, 27]. Aggregation is not universally observed, however. In
other studies of animal models of neutropenia and stimulation
Fig. 1. Arterial neutrophil (A) and monocyte (B) counts, and venous (C) and arterial (D) C5a levels during dialysis with ethylene oxide-sterilized
Cuprophan (CP-E, , N 5 5); steam-sterilized Cuprophan (CP-S, , N 5 6); Hemophan (HP, M, N 5 6); and Polysulfone (PS, E, N 5 6). Counts are
expressed as the ratio to pre-dialysis levels. The text label refers to the statistical comparison of minimum cell counts with the four membranes (A and
B) or the comparison of peak complement levels (C and D). Underscores join groups that are not different at the indicated significance level. Dashed
lines represent expected cell counts under a one-pool model with first order removal.
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with C5a or zymosan activated serum, neutrophils were predom-
inantly found singly in pulmonary capillaries, rather than as
aggregates in arterioles [18, 28]. Hence, it may be necessary to
resort to mechanisms involving systemic activation to account for
the rapid kinetics of neutropenia during Cuprophan dialysis.
Possible evidence for systemic activation of neutrophils also
comes from the F-actin results. The analysis above suggests that
early in dialysis, during the first 15 minutes or so, a significant
proportion of the cells in arterial blood had not yet been through
the dialyzer and had not been sequestered in the lungs. Never-
theless, by 15 minutes there was a substantial increase in arterial
neutrophil F-actin content (Fig. 3B). In contrast, the major
increase in CD11b expression on arterial neutrophils came well
after 15 minutes and may reflect the reappearance of previously
activated cells returning to circulation (Fig. 2B). The rise of
CD11b expression on arterial monocytes (Fig. 2D) was delayed
even longer, possibly reflecting the slower return of these cells to
circulation (compare Fig. 1 panels A and B).
Evidence of systemic activation does not indicate whether
neutrophils lodge in the pulmonary capillaries through adhesion
to endothelium, because of their mechanical properties, or both.
Nor does it rule out aggregation as a mechanism. Increased
CD11b expression on arterial neutrophils after 15 minutes of
dialysis may not be required to stimulate adherence to pulmonary
endothelial cells [29]. However, if the measured arterial plasma
concentrations are a true reflection of the amount of C5a (strictly
C5a des arg) available to bind to receptors on neutrophils,
assuming that the amount bound to and internalized by cells is
relatively small, such concentrations are probably not sufficient to
cause increases in the adhesion of neutrophils to human endothe-
lial cells [30].
In any case, increases in stiffness as a result of polymerization of
cytoskeletal actin occur at much lower C5a or fMLP concentra-
tions than those required to increase adhesion [16, 17]. The
evidence of the present study is also that F-actin is very sensitive
to low C5a concentrations. Considerable actin polymerization
occurred even with the very limited C5a production of polysulfone
membranes (Fig. 3). F-actin content appeared to reach a maxi-
mum in venous blood at the moderate levels of C5a produced by
dialysis with Hemophan, as venous neutrophil F-actin content for
Cuprophan was not different from Hemophan, in spite of much
higher C5a levels. In contrast, the arterial neutrophil F-actin
content for Cuprophan was significantly higher than that for
Hemophan, an observation consistent with the much deeper
neutropenia with Cuprophan. Therefore, we suggest that a change
in neutrophil mechanical properties due to recruitment of F-actin
Fig. 2. Venous (A and C) and arterial (B and D) neutrophil (PMN) and monocyte (MNC) CD11b expression. Symbols as in Figure 1. The text label
refers to the comparison of peak antigen levels. Underscores join groups that are not different at the indicated significance level.
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in their cytoskeleton is a plausible mechanism for dialysis neutro-
penia.
The return of both neutrophils and monocytes to circulation
despite continued elevated C5a levels at 180 minutes indicates
some loss of sensitivity to C5a. This loss of sensitivity is not
reflected in neutrophil CD11b expression or F-actin content, as
both remain elevated. Therefore it is difficult to explain the return
of neutrophils to circulation with either the stiffness or the
adhesion theory. For CD11b, possible explanations are that
another adhesion receptor is also involved (such as LAM-1 [31]),
or that changes in adhesiveness also involve conformational
changes to the CD11b/CD18 molecule, not simply the number of
receptors [32, 33]. For F-actin a possibility is that the deformabil-
ity of neutrophils depends not only on the F-actin content, but its
form and distribution. F-actin can be either bound to the cytoskel-
eton or exist in a short filament labile form [34, 35]. Labile F-actin
is unlikely to contribute as much to the stiffness of neutrophils. It
is possible that the F-actin initially formed when neutrophils are
activated is associated with the cytoskeleton, a possibility sug-
gested by assays that measure cytoskeletal associated actin (CAA)
[36]. If this is subsequently converted into a labile form of F-actin
then the stiffness of the cell may decline with no reduction in
F-actin content.
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APPENDIX
Abbreviations used in this article are: CP-E, ethylene oxide sterilized
Cuprophan membranes; CP-S, steam sterilized Cuprophan membranes;
EDTA, ethylene diamine tetra-acetic acid; ELISA, enzyme-linked immu-
nosorbent assay; FACSlyse, proprietary (Becton Dickinson) lysing and
fixing solution; F-actin, filamentous actin; FI, fluorescent intensity; FITC,
fluorescein isothiocyanate; fMLP, N-formyl-methionyl-leucyl-phenylala-
nine; G-actin, globular actin; HP, Hemophan membranes (steam steril-
ized); MdCN, median channel number of events acquired by the
FACScan; MNC, monocytes (mononuclear cells); NBD-phallacidin, N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)phallacidin; NFI, net fluorescent intensity;
PBS, phosphate buffered saline; PE, phycoerythrin; PMN, neutrophils
(polymorphonuclear leukocytes); PS, polysulfone membranes (ethylene
oxide sterilized); ZAS, zymosan activated serum.
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